CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Mark Hinton

OPENALEX: A5046087632↗ORCID: 0000-0002-2376-4420↗

Affiliations

Organizations

Camden and Islington NHS Foundation Trustauthorship · GB Early Intervention Foundationauthorship · GB Mental Health Australiaauthorship · AU Orygen Youth Healthauthorship · AU The University of Melbourneauthorship · AU University College Londonauthorship · GB

Public evidence

2 connected articles

Clinical and cost-effectiveness of contingency management for cannabis use in early psychosis: the CIRCLE randomised clinical trial.2019 · PubMed Central Open Access A randomised controlled trial of the clinical and cost-effectiveness of a contingency management intervention compared to treatment as usual for reduction of cannabis use and of relapse in early psychosis (CIRCLE): a study protocol for a randomised controlled trial.2016 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Mark Hinton - Medical Cannabis Research Engine